405 related articles for article (PubMed ID: 28284493)
1. Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planning.
Rylander S; Buus S; Pedersen EM; Bentzen L; Tanderup K
Radiother Oncol; 2017 Apr; 123(1):125-132. PubMed ID: 28284493
[TBL] [Abstract][Full Text] [Related]
2. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy.
De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA
Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.
Batchelar DL; Chung HT; Loblaw A; Law N; Cisecki T; Morton GC
Brachytherapy; 2016; 15(4):399-405. PubMed ID: 27180126
[TBL] [Abstract][Full Text] [Related]
4. The influence of a rectal ultrasound probe on the separation between prostate and rectum in high-dose-rate brachytherapy.
Rylander S; Buus S; Bentzen L; Pedersen EM; Tanderup K
Brachytherapy; 2015; 14(5):711-7. PubMed ID: 26164752
[TBL] [Abstract][Full Text] [Related]
5. Needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer evaluated by repeated MRI.
Buus S; Lizondo M; Hokland S; Rylander S; Pedersen EM; Tanderup K; Bentzen L
Brachytherapy; 2018; 17(1):50-58. PubMed ID: 28935450
[TBL] [Abstract][Full Text] [Related]
6. The effect of catheter displacement and anatomical variations on the dose distribution in MRI-guided focal HDR brachytherapy for prostate cancer.
Maenhout M; van der Voort van Zyp JRN; Borot de Battisti M; Peters M; van Vulpen M; van den Bosch M; Moerland MA
Brachytherapy; 2018; 17(1):68-77. PubMed ID: 28579419
[TBL] [Abstract][Full Text] [Related]
7. Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion.
De Brabandere M; Hoskin P; Haustermans K; Van den Heuvel F; Siebert FA
Radiother Oncol; 2012 Aug; 104(2):192-8. PubMed ID: 22857857
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging for prostate bed radiotherapy planning: An inter- and intra-observer variability study.
Barkati M; Simard D; Taussky D; Delouya G
J Med Imaging Radiat Oncol; 2016 Apr; 60(2):255-9. PubMed ID: 26568515
[TBL] [Abstract][Full Text] [Related]
10. Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning.
Batchelar D; Gaztañaga M; Schmid M; Araujo C; Bachand F; Crook J
Brachytherapy; 2014; 13(1):75-9. PubMed ID: 24080299
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric feasibility of ablative dose escalated focal monotherapy with MRI-guided high-dose-rate (HDR) brachytherapy for prostate cancer.
Hosni A; Carlone M; Rink A; Ménard C; Chung P; Berlin A
Radiother Oncol; 2017 Jan; 122(1):103-108. PubMed ID: 27916416
[TBL] [Abstract][Full Text] [Related]
12. A systematic study of imaging uncertainties and their impact on 125I prostate brachytherapy dose evaluation.
Lindsay PE; Van Dyk J; Battista JJ
Med Phys; 2003 Jul; 30(7):1897-908. PubMed ID: 12906208
[TBL] [Abstract][Full Text] [Related]
13. Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction.
Nesvacil N; Pötter R; Sturdza A; Hegazy N; Federico M; Kirisits C
Radiother Oncol; 2013 Apr; 107(1):75-81. PubMed ID: 23068712
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapy.
Nicolae A; Murgic J; Kruljac I; Dubnitzky L; D'Alimonte L; Lu L; Cumal A; Law N; Morton G; Loblaw A; Chung HT; Ravi A
Brachytherapy; 2018; 17(2):306-312. PubMed ID: 29239812
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric and workflow impact of synthetic-MRI use in prostate high-dose-rate brachytherapy.
Podgorsak AR; Venkatesulu BP; Abuhamad M; Harkenrider MM; Solanki AA; Roeske JC; Kang H
Brachytherapy; 2023; 22(5):686-696. PubMed ID: 37316376
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy.
Wang T; Press RH; Giles M; Jani AB; Rossi P; Lei Y; Curran WJ; Patel P; Liu T; Yang X
Br J Radiol; 2019 May; 92(1097):20190089. PubMed ID: 30912959
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer.
Schindel J; Muruganandham M; Pigge FC; Anderson J; Kim Y
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):387-93. PubMed ID: 23433797
[TBL] [Abstract][Full Text] [Related]
18. Improved prostate delineation in prostate HDR brachytherapy with TRUS-CT deformable registration technology: A pilot study with MRI validation.
Yang X; Rossi PJ; Jani AB; Mao H; Zhou Z; Curran WJ; Liu T
J Appl Clin Med Phys; 2017 Jan; 18(1):202-210. PubMed ID: 28291925
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
20. Penile bulb sparing in prostate cancer radiotherapy : Dose analysis of an in-house MRI system to improve contouring.
Böckelmann F; Hammon M; Lettmaier S; Fietkau R; Bert C; Putz F
Strahlenther Onkol; 2019 Feb; 195(2):153-163. PubMed ID: 30315483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
